A Longitudinal Examination of Aging With a Spinal Cord Injury: Cardiovascular, Cerebrovascular and Cognitive Consequences
NCT ID: NCT03023163
Last Updated: 2023-06-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
92 participants
OBSERVATIONAL
2016-12-31
2022-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Age on Cardiovascular, Cerebrovascular and Cognitive Health in Spinal Cord Injury
NCT01984476
Cardiovascular, Cerebrovascular, and Cognitive Function in Spinal Cord Injury
NCT02122991
Cardiovascular Disease Study
NCT00857194
Longitudinal Assessment of Spinal Cord Structural Plasticity Using DTI in SCI Patients
NCT03069222
Cardiovascular Function and Response to Stimulation Within the First Year After Spinal Cord Injury
NCT06841198
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Older SCI
Individuals that are between the ages of 50-75 years old, have a traumatic SCI, level of injury between C1-T12, non-ambulatory (wheelchair dependent), AIS grade A, B, or C, and injury occurred more than 1 year ago.
No interventions assigned to this group
Older Able-Bodied Controls
Individuals that are between the ages of 50-75 years old and primary language is English.
No interventions assigned to this group
Longitudinal SCI
Individuals that are between the ages of 28-54 years old and previously participated in the Impact of Age on Cardiovascular, Cerebrovascular, and Cognitive Health study in a 3-5 year span.
Longitudinal
Participants that completed the Impact of Age on Cardiovascular, Cerebrovascular, Cerebrovascular and Cognitive Health study, will be re-assessed again to compare longitudinal (3-5 years) change in blood pressure, cerebral blood flow, arterial stiffness and cognitive health.
Longitudinal Able-Bodied Controls
Individuals that are between the ages of 28-54 years old and previously participated in the Impact of Age on Cardiovascular, Cerebrovascular, and Cognitive Health study in a 3-5 year span.
Longitudinal
Participants that completed the Impact of Age on Cardiovascular, Cerebrovascular, Cerebrovascular and Cognitive Health study, will be re-assessed again to compare longitudinal (3-5 years) change in blood pressure, cerebral blood flow, arterial stiffness and cognitive health.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Longitudinal
Participants that completed the Impact of Age on Cardiovascular, Cerebrovascular, Cerebrovascular and Cognitive Health study, will be re-assessed again to compare longitudinal (3-5 years) change in blood pressure, cerebral blood flow, arterial stiffness and cognitive health.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Study 2) Between the ages of 28-54 years old
* Completed Impact of Age on Cardiovascular, Cerebrovascular and Cognitive Health study
* For Both:
* Primary language is English
* Level of injury between C1-T12;
* Non-ambulatory (wheelchair dependent);
* AIS grade A, B, or C;
* Injury occurred more than 1 year ago.
Exclusion Criteria
* Controlled or uncontrolled hypertension or Diabetes mellitus;
* Documented history of traumatic brain injury;
* Stroke
* Epilepsy or seizure disorders;
* Multiple sclerosis \& Parkinson's disease;
* Psychiatric disorders (post-traumatic stress disorder, schizophrenia, bipolar disorder);
* Alzheimer's disease \& dementia
28 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kessler Foundation
OTHER
James J. Peters Veterans Affairs Medical Center
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jill M. Wecht, Ed.D.
Research Health Scientist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jill Wecht, EdD
Role: PRINCIPAL_INVESTIGATOR
James J Peters VA Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kessler Foundation Research Center
West Orange, New Jersey, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
WEC-16-039
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.